169 related articles for article (PubMed ID: 33992765)
1. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015-2018.
Tsuzuki S; Matsunaga N; Yahara K; Shibayama K; Sugai M; Ohmagari N
Int J Infect Dis; 2021 Jul; 108():119-124. PubMed ID: 33992765
[TBL] [Abstract][Full Text] [Related]
2. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
Tsuzuki S; Matsunaga N; Yahara K; Gu Y; Hayakawa K; Hirabayashi A; Kajihara T; Sugai M; Shibayama K; Ohmagari N
J Infect Chemother; 2020 Apr; 26(4):367-371. PubMed ID: 31801696
[TBL] [Abstract][Full Text] [Related]
3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators
Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
[TBL] [Abstract][Full Text] [Related]
4. Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019.
Gasser M; Cassini A; Lo Fo Wong D; Gelormini M; Nahrgang SA; Zingg W; Kronenberg AO
Euro Surveill; 2023 May; 28(20):. PubMed ID: 37199988
[TBL] [Abstract][Full Text] [Related]
5. The burden of bacterial antimicrobial resistance in Croatia in 2019: a country-level systematic analysis.
Meštrović T; Ikuta KS; Swetschinski L; Gray A; Robles Aguilar G; Han C; Wool E; Gershberg Hayoon A; Murray CJ; Naghavi M
Croat Med J; 2023 Aug; 64(4):272-283. PubMed ID: 37654039
[TBL] [Abstract][Full Text] [Related]
6. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators
Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
[TBL] [Abstract][Full Text] [Related]
7. Stime dell'antibiotico-resistenza in Italia e in Europa occidentale nel 2019: un'analisi comparativa basata su MICROBE.
Zamagni G; Forni S; Iavicoli I; Guicciardi S; Buonsenso D; Ferrara P; De Luca M; Golinelli D; Sanmarchi F; Collatuzzo G; Gemmi F; Naghavi M; Sabbatucci M; Monasta L
Epidemiol Prev; 2024; 48(1):48-59. PubMed ID: 38482785
[TBL] [Abstract][Full Text] [Related]
8. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.
Cassini A; Högberg LD; Plachouras D; Quattrocchi A; Hoxha A; Simonsen GS; Colomb-Cotinat M; Kretzschmar ME; Devleesschauwer B; Cecchini M; Ouakrim DA; Oliveira TC; Struelens MJ; Suetens C; Monnet DL;
Lancet Infect Dis; 2019 Jan; 19(1):56-66. PubMed ID: 30409683
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.
Waterlow NR; Cooper BS; Robotham JV; Knight GM
PLoS Med; 2024 Mar; 21(3):e1004301. PubMed ID: 38484006
[TBL] [Abstract][Full Text] [Related]
10. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators
Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
[TBL] [Abstract][Full Text] [Related]
12. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go.
Friedrich AW
Wien Med Wochenschr; 2019 Feb; 169(Suppl 1):25-30. PubMed ID: 30623278
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
[TBL] [Abstract][Full Text] [Related]
14. Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan.
Tsuzuki S; Koizumi R; Matsunaga N; Ohmagari N
Infect Dis Ther; 2023 Jul; 12(7):1823-1834. PubMed ID: 37318709
[TBL] [Abstract][Full Text] [Related]
15. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.
de Kraker ME; Davey PG; Grundmann H;
PLoS Med; 2011 Oct; 8(10):e1001104. PubMed ID: 22022233
[TBL] [Abstract][Full Text] [Related]
16. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators
Lancet Reg Health Am; 2023 Sep; 25():100561. PubMed ID: 37727594
[TBL] [Abstract][Full Text] [Related]
17. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
18. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
[TBL] [Abstract][Full Text] [Related]
19. Code-Sharing in Cost-of-Illness Calculations: An Application to Antibiotic-Resistant Bloodstream Infections.
Naylor NR; Yamashita K; Iwami M; Kunisawa S; Mizuno S; Castro-Sánchez E; Imanaka Y; Ahmad R; Holmes A
Front Public Health; 2020; 8():562427. PubMed ID: 33330310
[No Abstract] [Full Text] [Related]
20. Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan.
Tsuzuki S; Matsunaga N; Ohmagari N
Glob Health Med; 2020 Jun; 2(3):164-167. PubMed ID: 33330801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
